section name header
Index
5-Alpha-Reductase Inhibitors (5ARI) for Benign Prostatic Hyperplasia
Adjuvant Radiotherapy Following Radical Prostatectomy for Prostate Cancer with High Risk Characteristics
Allopurinol for Chronic Prostatitis
Benign Prostatic Hyperplasia - Related Resources
Combination of Doxazosin and Finasteride Compared with Either Drug Alone or Placebo for Benign Prostatic Hyperplasia
Conservative Management for Postprostatectomy Urinary Incontinence
Early Versus Deferred Androgen Suppression in the Treatment of Advanced Prostatic Cancer
Evidence summary
Fibrin Sealant Use for Minimising Peri-Operative Allogeneic Blood Transfusion
Five-Alpha-Reductase Inhibitors for Prostate Cancer Prevention
Holmium Laser Prostatectomy Vs. Turp
International Prostate Symptom Score (IPSS)
Laser Prostatectomy for Benign Prostatic Obstruction
Naftopidil for the Treatment of Lower Urinary Tract Symptoms Compatible with Benign Prostatic Hyperplasia
Phytotherapy for Benign Prostatic Hyperplasia
Prostate Cancer - Related Resources
Prostatic Volume Estimation (Ultrasonography)
Psa for Screening of Prostate Cancer
Public Health Policy on Screening for Cancer - Related Resources
Radical Prostatectomy Versus Watchful Waiting for Newly Diagnosed Prostate Cancer
Screening for Ovarian Cancer
Serenoa Repens for Benign Prostatic Hyperplasia
Surgery
Tamsulosin for Benign Prostatic Hyperplasia
Terazosin for Benign Prostatic Hyperplasia
Testosterone Supplementation for Older Men
Transurethral Microwave Thermotherapy for Benign Prostatic Hyperplasia
Transurethral Resection of the Prostate for Prostatic Hyperplasia
Ultrasonographic Examinations: Indications and Preparation of the Patient - Related Resources
Very Large Prostate